Noémi Nyolczas

Learn More
Aims Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy in a larger heart failure cohort. Methods and results This multinational, randomized,(More)
heart rate of mice prolonged their life span and, more recently, that reducing the heart rate of monkeys with beta-blockers or sino-atrial node ablation retards coronary atherosclerosis [3]. In humans, mortality reduction has been shown to occur, in persons with existing coronary disease, if the heart rate is reduced with beta-blockers by more than 14(More)
  • 1